Despite Market Headwinds, Organigram Is Making Progress Toward Its Goals
Like most marijuana stocks, Organigram (NASDAQ: OGI) has underperformed the market in recent years, but in its most recent fiscal first quarter, the company showed off strong growth and a narrowing loss on the bottom line.
In this episode of "Beat and Raise" recorded on Jan. 21, Fool contributors Rachel Warren and Brian Withers discuss Organigram's prospects and what makes it unique.
Source Fool.com
